Thanks for the questions. I am not sure what you mean by the statements below regarding the Vax. Can you please clarify a little? The Corneo question is a good one as no mention was made in the Quarterly. I believe our main target in emerging markets is China but I will seek clarification and question timelines. Thanks again for the questions.
"The background work on Vax delivery methods and devices. What are they? and how will this be arranged for future trials. (This has been mentioned briefly via email)"
AHZ Price at posting:
36.5¢ Sentiment: Buy Disclosure: Held
